RiverFront Investment Group’s Amgen AMGN Stock Holding History

RiverFront Investment Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.71M	Buy	13,012 +6,595	+103%	+$2.26M	0.06%	116
2026 Q1	$2.26M	Buy	6,417 +3,687	+135%	+$1.31M	0.03%	136
2025 Q4	$894K	Buy	2,730 +254	+10%	+$80.6K	0.01%	175
2025 Q3	$699K	Buy	2,476 +39	+2%	+$11.3K	0.01%	190
2025 Q2	$680K	Buy	+2,437	New	+$690K	0.01%	179
2021 Q3	–	Sell	-1,057	Closed	-$258K	–	83
2021 Q2	$258K	Buy	1,057 +38	+4%	+$9.35K	0.01%	117
2021 Q1	$254K	Buy	+1,019	New	+$243K	0.01%	83

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

RiverFront Investment Group's AMGN Position: Q2 2026 in Review

RiverFront Investment Group increased its Amgen (AMGN) stake by 103% in Q2 2026, buying an estimated $2.26M and bringing the position to 13,012 shares worth $4.71M. The position accounts for 0.06% of the portfolio, ranked #116.

RiverFront Investment Group first reported a position in AMGN in Q1 2021 and has held it in 7 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

RiverFront Investment Group held 13,012 shares of Amgen worth $4.71M as of Q2 2026.
RiverFront Investment Group bought 6,595 Amgen shares in Q2 2026, an estimated $2.26M.
Amgen made up 0.06% of RiverFront Investment Group's portfolio in Q2 2026, its #116 holding.
RiverFront Investment Group first reported a position in Amgen in Q1 2021 and has held it in 7 quarters since.
1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on RiverFront Investment Group's 13F filing for Q2 2026, filed 29 Jul 2026.